Viatris inc. announces receipt of the first fda approval for generic version of symbicort® inhalation aerosol, breyna™ (budesonide and formoterol fumarate dihydrate inhalation aerosol), in partnership with kindeva

Approval continues track record of successful firsts in developing complex generic medicines to help increase patient access pittsburgh and st. paul, minn.

VTRS Ratings Summary

VTRS Quant Ranking